viewCollagen Solutions PLC

Collagen Sol PLC - Appointment of Non-Executive Director

RNS Number : 2889B
Collagen Solutions PLC
06 June 2019

6 June 2019


Collagen Solutions Plc

("Collagen" or the "Company"")


Appointment of Non-Executive Director


Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces the appointment of Wade Rosen to the Company's Board as a Non-Executive Director with immediate effect.


Mr Rosen joins the board following the completion of the strategic investment in the Company by Rosen's Diversified, Inc. (RDI) pursuant to which it was agreed that RDI would be entitled to nominate a non-executive director.  Mr Rosen is a successful business leader, entrepreneur, and co-founder of two business-to-business technology companies, ThrivePass Inc. ("ThrivePass") and Wishlist Rewards LLC ("Wishlist").  Mr Rosen currently serves as a Director of RDI, and as Executive Vice President at Scientific Life Solutions, a subsidiary of RDI. He also serves as a Director for Wishlist and Flagship Biosciences, Inc. and as Chairman of the Board at ThrivePass. Mr. Rosen holds a Bachelor of Business Administration (BBA) in Information Technology & E-Commerce from The University of Denver, and a Masters of Business Administration (MBA) from the Instituto de Empresa in Spain.


David Evans, Chairman of Collagen Solutions, said: "We are delighted to welcome Wade to the Board. Wade arrives at a pivotal time for the Company and we are confident that his appointment will bring immediate value to the Board." 


Pursuant to Schedule 2 (g) of the AIM Rules for Companies, Wade John Rosen (aged 34) has held the following directorships or partnerships in the past five years:



Wellness by Wishlist Inc (doing business as ThrivePass Inc.)

Wishlist Rewards LLC

Flagship Biosciences Inc.

Rosen's Diversified Inc.


Connect First Inc.


Mr Rosen does not currently directly hold any shares in the Company but is a director and shareholder of RDI, which holds 83,600,000 Ordinary Shares.

There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.




Collagen Solutions Plc


Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO




Cenkos Securities Plc (Nominated Adviser and Broker)


Giles Balleny (Corporate Finance)

Tel: 0207 397 8900

Max Gould




Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected] 

Anna Dunphy

Mob: 07876 741 001





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Collagen Solutions PLC

Price: 2.65

Market: LSE
Market Cap: £11.76 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Collagen Solutions reports strong growth in its tissue business in first half

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence update Proactive London's Andrew Scott on first half performance - their third consecutive six-month period of double-digit sales growth. Revenues increased by 14% to £2.23mln in the period ended September 30. Tissue sales more...

on 3/12/19